They now describe their findings about an intermediate stage in this process in Science Advances. Eukaryotic cells contain a ...

The addition of lenvatinib and pembrolizumab to transarterial chemoembolization extended PFS for patients with intermediate-stage hepatocellular carcinoma, according to randomized phase 3 study ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial chemoembolization. Patients with intermediate-stage hepatocellular carcinoma ...

"For over 20 years, TACE has been the standard treatment for intermediate-stage HCC, but its efficacy has been limited," said Dr. Llovet, who is Director of Mount Sinai's Liver Cancer Program and ...

Thaker, MD The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy ...

After a surprise failure in advanced liver cancer, Merck & Co. and Eisai are hoping new data can make their Keytruda-Lenvima combination a standard of care in intermediate-stage disease.